The NIH has awarded a five-year grant worth $20 million to researchers at the Fred Hutchinson Cancer Research Center in Seattle to develop a treatment for HIV. Scientists at the research center are testing an approach in which they genetically alter an HIV-positive patient's cells to make them resistant to the virus.

Related Summaries